Efficacy of probiotics in reducing the severity and duration of neonatal hyperbilirubinemia

Last registered on September 26, 2024

Pre-Trial

Trial Information

General Information

Title
Efficacy of probiotics in reducing the severity and duration of neonatal hyperbilirubinemia
RCT ID
AEARCTR-0014083
Initial registration date
August 18, 2024

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
September 26, 2024, 12:24 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

Region

Primary Investigator

Affiliation
Pakistan Air Force Hospital, Islamabad, Pakistan

Other Primary Investigator(s)

Additional Trial Information

Status
On going
Start date
2024-08-01
End date
2024-12-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
Neonatal hyperbilirubinemia is cause by raised serum total bilirubin levels usually manifests as jaundice and is commonly an indirect type.
There is a dearth of available in literature that illuminate the beneficial role of probiotics in
significantly reducing the total serum bilirubin. If the use of probiotics remarkably reduces the
serum bilirubin levels in neonatal hyperbilirubinemia, it would routinely be advised in the
future for newborns with neonatal jaundice. It would help reduce the side effects of
phototherapy, hospital admission, maternal-infant separation, and prolonged hospital
stays. Ultimately reducing the overall morbidity associated with neonatal hyperbilirubinemia.
The objective of the study is to compare the mean reduction in bilirubin and mean duration of neonatal hyperbilirubinemia
with probiotic and phototherapy in comparison with phototherapy alone.
External Link(s)

Registration Citation

Citation
Ain, Qurat Ul. 2024. "Efficacy of probiotics in reducing the severity and duration of neonatal hyperbilirubinemia ." AEA RCT Registry. September 26. https://doi.org/10.1257/rct.14083-1.0
Experimental Details

Interventions

Intervention(s)
160 neonates, meeting the
selection criteria, admitted in Neonatal Intensive Care of the Pediatrics department at Pakistan Air Force
Hospital, Islamabad, will be enrolled in the study, after obtaining informed written consent from
parents/guardians. Demographic details like registration number, age,
gender, birth weight, gestational age at delivery, type of feeding, and serum total bilirubin level
at baseline will be noted. The neonates will be divided randomly into two groups by allocating
even numbers to Group A and odd numbers to Group B participants. In group A, neonates will
be given phototherapy along with oral probiotics (Enterogermina containing Bacillus Clausii –

2.5ml twice daily for 2 consecutive days) and group B will be given phototherapy by
consecutive non-probability sampling. The baseline STB level will be noted. Then neonates will
be followed-up for 12, 24, and 48 hours of treatment in the NICU. On each follow-up, a 2ml
blood sample will be taken in a red top serum vial and sent to the laboratory for assessment of
bilirubin level. STB will be assessed at 12, 24, and 48 hours of treatment and a reduction in
mean STB level at 12, 24, and 48 hours of treatment will be calculated from baseline (as per the
operational definition). Moreover, the effect of probiotics on the major clinical course including
the duration of phototherapy, duration of hospitalization, and the need for exchange transfusion
will be assessed. All the data will be collected by using the proforma. To reduce
selection bias within the study and maintain the quality of the data, the researcher along with
paramedical staff will collect and maintain all data.
Intervention (Hidden)
Intervention Start Date
2024-08-01
Intervention End Date
2024-12-31

Primary Outcomes

Primary Outcomes (end points)
All the collected data will be recorded and analyzed in SPSS Software (version 23). Numerical
variables like age, weight, gestational age, bilirubin level (before, and after 12, 24, and 48 hours
of treatment), duration of phototherapy, hospital stay and reduction in STB will be calculated as
mean ± standard deviation. Frequency and percentage will be calculated for qualitative variables
like gender and feeding pattern. For comparison between the groups, the independent samples t-
test will be applied for quantitative variables. The paired t-test will be used to compare the mean
reduction in bilirubin level in both groups pre and post-intervention and a p-value of ≤0.05 will
be taken as significant. The effect modifiers such as gestational age at birth, gender, and mode of
feeding will be stratified by using post stratified independent sample t-test.
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
Randomized control trial
Experimental Design Details
Randomization Method
Consecutive non-probability sampling
Randomization Unit
no cluster randomization was done
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
160 neonates
Sample size: planned number of observations
same as above
Sample size (or number of clusters) by treatment arms
80 in each group i.e. one with phototherapy alone and the other with phototherapy along with probiotics
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
90%
Supporting Documents and Materials

Documents

Document Name
Synopsis
Document Type
proposal
Document Description
File
Synopsis

MD5: 7752da1f63470231bbc008c911de8faa

SHA1: 0f3ae7c3456aef5ced29311524b39211827f39f0

Uploaded At: August 18, 2024

IRB

Institutional Review Boards (IRBs)

IRB Name
Ethical review committee, PAF Hospital
IRB Approval Date
2024-04-29
IRB Approval Number
240429
Analysis Plan

Analysis Plan Documents

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials